PROFILE FOR PDCO.
EARNINGS HISTORY
| -0.02 MISS | Dec, 05, 2024 Actual: 0.47 Estimated: 0.49 |
| -0.08 MISS | Aug, 28, 2024 Actual: 0.24 Estimated: 0.32 |
| 0 MET | Jun, 18, 2024 Actual: 0.82 Estimated: 0.82 |
| -0.01 MISS | Feb, 28, 2024 Actual: 0.59 Estimated: 0.6 |
| -0.08 MISS | Nov, 29, 2023 Actual: 0.5 Estimated: 0.58 |
| 0 MET | Aug, 30, 2023 Actual: 0.4 Estimated: 0.4 |
| +0.14 BEAT | Jun, 21, 2023 Actual: 0.84 Estimated: 0.7 |
| +0.02 BEAT | Mar, 02, 2023 Actual: 0.62 Estimated: 0.6 |
NEWS FEED
 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP and PDCO on Behalf of Shareholders 2025-01-06 14:27:00 NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: |  | PDCO Stock Gains on the News of Acquisition Deal With Patient Square 2024-12-16 08:55:14 Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion. |  | What Does Dental Player Patterson’s $4.1 Billion Deal Mean For Other Players? 2024-12-12 14:32:59 On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion. |  | Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade) 2024-12-12 09:00:00 Patterson Companies’ shares surged 35.9% after announcing an all-cash buyout by Patient Square Capital, valuing the company at $4.1 billion. Despite the buyout, some investors feel the deal leaves money on the table, but the stock’s appreciation is a net positive. The go-shop period allows management to seek better offers, suggesting potential for a higher bid, making it wise to hold shares. |  | $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Patterson Companies, Inc. – PDCO 2024-12-11 17:12:00 NEW YORK , Dec. 11, 2024 /PRNewswire/ — Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Patterson Companies, Inc. (NASDAQ: PDCO ), relating to the proposed merger with Patient Square Capital. |  | Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal 2024-12-11 10:18:16 On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion. |  | PDCO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Patterson Companies, Inc. Is Fair to Shareholders 2024-12-11 08:41:00 NEW YORK–(BUSINESS WIRE)–Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Patterson Companies, Inc. (NASDAQ: PDCO) to Patient Square Capital for $31.35 in cash per share is fair to Patterson shareholders. Halper Sadeh encourages Patterson shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersadeh.com or zhalper@halpersadeh.com. The investigation concerns wheth. |  | Patterson Cos. to Be Acquired by Patient Square Capital for $4.1 Billion 2024-12-11 07:32:00 Shareholders will receive $31.35 in cash per share under terms of the deal. |  | Rectangle Health Collaborates with Patterson Dental to Enhance Payment Solutions for Healthcare Providers 2024-12-10 09:00:00 Patterson Approved Vendor status will pave the way for customers to securely use new payments capabilities. VALHALLA, N.Y. |  | PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins 2024-12-05 12:10:26 Patterson Companies’ overall topline in the second quarter of fiscal 2025 benefits from strength in its Animal Health segment. |